Online citations, reference lists, and bibliographies.

Treatment Of Peritoneal Carcinomatosis In Gastric Cancers

Cécile Brigand, Charles Christian Arvieux, F. N. Gilly, Olivier Glehen
Published 2004 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
Peritoneal carcinomatosis may occur after curative surgery of any gastrointestinal carcinoma, but it is however the most frequent form of evolution after curative resection of gastric carcinoma and is present at the time of surgery in many cases. This locoregional extension of cancer has a poor prognosis, with a great mortality and a poor quality of life. It is sometimes considered of such a poor prognosis that patients do not go through any resection or palliative procedure. Techniques of radiotherapy, chemotherapy and intraperitoneal chemotherapy have been used with moderate clinical efficacy. Since the 1990s, intraoperative hyperthermic peritoneal chemotherapy combined with comprehensive cytoreductive surgery has been proposed to improve prognosis of patients with peritoneal carcinomatosis from gastric origin as well as carcinomatosis from colorectal origin or pseudomyxoma peritonei.
This paper references
Intraperitoneal chemo-hyperthermia with mitomycin C for gastric cancer patients with peritoneal carcinomatosis.
A. C. Sayag-Beaujard (1999)
Intraopera - tive lavage for cytological examination in 1 , 297 patients with gastric carcinoma
M Ikeguchi (1999)
10.1093/annonc/mdh312
Combination of irinotecan (CPT-11) plus oxaliplatin (L-OHP) as first-line treatment in locally advanced or metastatic gastric cancer: a multicentre phase II trial.
John Souglakos (2004)
10.1016/j.ejso.2004.04.013
Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial.
H. H. Hartgrink (2004)
Intra - peritoneal chemotherapy for ovarian carcinoma : Results of long - term follow - up
O Glehen (2002)
10.1046/j.1365-2168.2002.02220.x
Value of palliative resection in gastric cancer.
H. H. Hartgrink (2002)
Surgical treatment for advanced gastric cancer.
Shinichi Maekawa (1996)
10.1016/S0016-5085(03)83984-7
Complications of gastrectomy following CPT-11 based neoadjuvant chemotherapy for gastric cancer
Stuart G. Marcus (2003)
Potential for therapy of drugs and hyperthermia.
G. Hahn (1979)
Treatment of peritoneal car - cinomatosis arising from gastric cancer by cytoreductive surgery and intraperitoneal che - mohyperthermia
AD Stephens (2004)
10.1053/ejso.1999.0780
Problems with intraoperative hyperthermic peritoneal chemotherapy for advanced gastric cancer.
Stephan T. Samel (2000)
10.1001/archsurg.138.1.26
Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis.
P. Shen (2003)
: Effi cacy and feasibility in clinical practice
E Newman (2001)
10.1002/1097-0142(19900101)65:1<65::AID-CNCR2820650115>3.0.CO;2-L
Continuous hyperthermic peritoneal perfusion for the treatment of peritoneal dissemination in gastric cancers and subsequent second-look operation.
T. Fujimura (1990)
10.1097/00000658-198807000-00005
Intraperitoneal Hyperthermic Perfusion Combined with Surgery Effective for Gastric Cancer Patients with Peritoneal Seeding
Shigeru Fujimoto (1988)
Japanese Classification of Gastric Carcinoma , 2 nd Engl ed
PA Lauren (1998)
motherapy in gastric cancer : A review and updated meta - analysis
J Souglakos (2002)
Sensitivity of human cells to mild hyperthermia.
Elwood P. Armour (1993)
10.1002/ssu.10042
Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer.
Paul H Sugarbaker (2003)
Complete omentectomy and extensive lymphadenectomy with gastrectomy improves the survival of gastric cancer patients with metastases in the adjacent peritoneum.
Akeo Hagiwara (1998)
10.1007/978-1-4613-1247-5_18
Methodologic considerations in treatment using intraperitoneal chemotherapy.
Andrew M. Averbach (1996)
10.1259/0007-1285-53-633-920-b
Thermal tolerance.
Robert A. Read (1980)
10.1038/bjc.1996.468
Recurrences and related characteristics of gastric cancer.
Y. Maehara (1996)
10.1046/j.1365-2168.2000.01538.x
Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer.
Wim P Ceelen (2000)
10.1016/s1055-3207(03)00048-6
Peritonectomy procedures.
P. Sugarbaker (1996)
10.1002/1097-0142(197910)44:4<1476::AID-CNCR2820440442>3.0.CO;2-R
Intraperitoneal free cancer cells and their viability in gastric cancer.
Yasuo Iitsuka (1979)
Relationship between area of serosal invasion and intraperitoneal free cancer cells in patients with gastric cancer.
Masahide Ikeguchi (1994)
10.1002/1097-0142(19880715)62:2<440::AID-CNCR2820620232>3.0.CO;2-N
Palliative surgery for gastric cancer.
M. Hallissey (1988)
A new surgical approach (peritonectomy) for the treatment of peritoneal dissemination.
Y. Yonemura (1999)
10.1002/1097-0142(20010301)91:5<918::AID-CNCR1081>3.0.CO;2-W
Neoadjuvant therapy for patients with locally advanced gastric carcinoma with etoposide, doxorubicin, and cisplatinum. Closing results after 5 years of follow-up.
C. Schuhmacher (2001)
10.1002/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O
Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study.
B Sadeghi (2000)
10.1002/1097-0142(19930515)71:10<2926::AID-CNCR2820711007>3.0.CO;2-X
Epidemiology of intestinal and diffuse types of gastric carcinoma. A time-trend study in Finland with comparison between studies from high- and low-risk areas.
Pekka Laurén (1993)
10.1002/bjs.4164
Prospective study of peritoneal recurrence after curative surgery for gastric cancer.
F. Roviello (2003)
10.1007/s101200100013
A controlled clinical study of serosa-invasive gastric carcinoma patients who underwent surgery plus intraperitoneal hyperthermo-chemo-perfusion (IHCP)
Jin-Young Kim (2001)
10.1159/000011847
Heated Intraoperative Intraperitoneal Mitomycin C and Early Postoperative Intraperitoneal 5-Fluorouracil: Pharmacokinetic Studies
P. Jacquet (1998)
10.1002/(SICI)1097-0142(19970301)79:5<884::AID-CNCR3>3.0.CO;2-C
Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery.
S. Fujimoto (1997)
Lack of effi cacy of prophylactic continuous hyperthermic peritoneal perfusion on subsequent peritoneal recurrence and survival in patients with advanced gastric cancer
S Samel (2002)
Gastrec - tomy , peritonectomy , and perioperative intraperitoneal chemotherapy : The evolution of treatment strategies for advanced gastric can
B Sadeghi (2003)
10.1007/BF01658884
The survival benefit of resection in patients with advanced stomach cancer: The norwegian multicenter experience
Trond Haugstvedt (2005)
10.1002/ejs.6161681106
Chemotherapy in gastric cancer: a review and updated meta-analysis.
Karl-Gunnar Janunger (2002)
An update on the anticancer effects of a combination of chemotherapy and hyperthermia.
Joan M. C. Bull (1984)
[Extended lymph-node dissection for gastric cancer].
M. Huguier (1999)
10.1002/1097-0142(20010701)92:1<71::AID-CNCR1293>3.0.CO;2-9
Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy.
Dominique M Elias (2001)
10.1046/j.1365-2168.2000.01360.x
Recurrence following curative resection for gastric carcinoma.
Chan Hui Yoo (2000)
Digestive surgery combined with peritonectomy procedures and intraperitoneal chemo - hyperthermia in abdominal cancers with peritoneal carcinoma - tosis : A phase II study
P Shen (2003)
10.1016/j.gassur.2003.12.014
Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer
Jason John Hall (2004)
10.1016/S1091-255X(01)00054-3
Neoadjuvant chemotherapy with CPT-11 and cisplatin downstages locally advanced gastric cancer
Elliot Newman (2002)
10.1200/jco.1993.11.8.1441
Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials.
J. Hermans (1993)
10.3748/wjg.v8.i6.1023
Intravenous chemotherapy for resected gastric cancer: meta-analysis of randomized controlled trials.
Jian-Kun Hu (2002)
rst-line treatment in locally advanced or metastatic gastric cancer: A multicentre phase II trial
M Yoshida (2004)
10.1016/S0140-6736(95)90637-1
Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients
J. Bonenkamp (1995)
Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study.
Y. Yonemura (2001)
10.1002/jso.2930530412
Prognostic value of the number of metastatic lymph nodes in gastric cancer with radical surgery.
Hirosi Isozaki (1993)
Enhancement by hyperthermia of the in vitro cytotoxicity of mitomycin C toward hypoxic tumor cells.
B. Teicher (1981)
10.1007/s10434-999-0790-0
Morbidity and Mortality Analysis of 200 Treatments With Cytoreductive Surgery and Hyperthermic Intraoperative Intraperitoneal Chemotherapy Using the Coliseum Technique
A. D. Stephens (1999)
10.1016/S0039-6060(96)80145-0
Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination.
Y. Yonemura (1996)
: A prospective phase II study
SG Marcus (2003)
10.1007/978-1-4613-1247-5_6
Observations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiology.
P. Sugarbaker (1996)
10.1002/1097-0142(19940415)73:8<2048::AID-CNCR2820730806>3.0.CO;2-Q
Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study.
R. Hamazoe (1994)
10.1159/000012016
Efficacy of Continuous Hyperthermic Peritoneal Perfusion for the Prophylaxis and Treatment of Peritoneal Metastasis of Advanced Gastric Cancer: Evaluation by Multivariate Regression Analysis
Kazuo Hirose (1999)



This paper is referenced by
10.3892/MCO.2016.918
A retrospective analysis of hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis.
Meiqin Yuan (2016)
Survival and Prognostic Factors of Patients with Advanced CY 1 / P 0 Gastric Cancer
(2016)
10.1016/j.biomaterials.2016.04.012
Genipin-crosslinked gelatin microspheres as a strategy to prevent postsurgical peritoneal adhesions: In vitro and in vivo characterization.
Kaat De Clercq (2016)
10.1007/s00109-006-0115-8
Inhibitory effects of a specific phage-displayed peptide on high peritoneal metastasis of gastric cancer
Feihu Bai (2006)
10.1021/acs.molpharmaceut.7b00349
Intraperitoneal Delivery of Cisplatin via a Hyaluronan-Based Nanogel/in Situ Cross-Linkable Hydrogel Hybrid System for Peritoneal Dissemination of Gastric Cancer.
S. Ohta (2017)
10.1080/00015458.2006.11679977
Prognostic Factors in Gastric Carcinoma with Peritoneal Dissemination
Dong Yi Kim (2006)
10.1245/s10434-014-4082-y
Clinical Significance of Cytological Status of Peritoneal Lavage Fluid During Intraperitoneal Chemotherapy for Gastric Cancer with Overt Peritoneal Dissemination
S. Emoto (2014)
DOES PRIMARY TUMOR RESECTION AFFECT SURVIVAL IN ELDERLY PATIENTS WITH METASTATIC GASTRIC CANCER
Fatma Yalcin Musri (2016)
10.1007/s00595-013-0674-6
Intraperitoneal administration of cisplatin via an in situ cross-linkable hyaluronic acid-based hydrogel for peritoneal dissemination of gastric cancer
S. Emoto (2013)
10.1007/s10120-011-0063-z
Gastric linitis plastica: which role for surgical resection?
Corrado Pedrazzani (2011)
10.1245/s10434-012-2687-6
Palliative Resection for Advanced Gastric and Junctional Adenocarcinoma: Which Patients will Benefit from Surgery?
Christophe Mariette (2012)
10.1186/1477-7819-4-85
Cerebral edema in a patient following cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemoperfusion
Rajalakshmi L Nair (2006)
10.1016/j.jconrel.2012.03.021
Effective transgene expression without toxicity by intraperitoneal administration of PEG-detachable polyplex micelles in mice with peritoneal dissemination.
Michiaki Kumagai (2012)
10.1002/jcb.25593
Therapeutic Cell-Cycle-Decoy Efficacy of a Telomerase-Dependent Adenovirus in an Orthotopic Model of Chemotherapy-Resistant Human Stomach Carcinomatosis Peritonitis Visualized With FUCCI Imaging.
Shuya Yano (2017)
10.1016/j.phymed.2018.01.006
Acetonic extracts of the endolichenic fungus EL002332 isolated from Endocarpon pusillum exhibits anticancer activity in human gastric cancer cells.
Yi Yang (2018)
Ethical issues related to chemotherapy in patients with gastric cancer
John K. Triantafillidis (2007)
10.1038/s41598-020-66637-y
Observational Study of Peritoneal Washing Cytology-Positive Gastric Cancer without Gross Peritoneal Metastasis in Patients who Underwent Radical D2 Gastrectomy
Hyun-Jeong Shim (2020)
10.18632/oncotarget.5595
Free intraperitoneal tumor cells and outcome in gastric cancer patients: a systematic review and meta-analysis
Mathieu Pecqueux (2015)
10.1016/j.biomaterials.2012.10.077
Docetaxel-loaded thermoresponsive conjugated linoleic acid-incorporated poloxamer hydrogel for the suppression of peritoneal metastasis of gastric cancer.
Woo Kyun Bae (2013)
10.1111/j.1349-7006.2012.02274.x
Antitumor effect and pharmacokinetics of intraperitoneal NK105, a nanomicellar paclitaxel formulation for peritoneal dissemination.
S. Emoto (2012)
Semantic Scholar Logo Some data provided by SemanticScholar